Subscribe to RSS
DOI: 10.1055/s-0031-1273239
© Georg Thieme Verlag KG Stuttgart · New York
Importance of Complete Haematological Workup for Relatives of Young Patients presenting Central Retinal Vein Occlusion
Stellenwert einer vollständigen hämatologischen Abklärung bei Familienangehörigen von jungen Patienten mit Zentralvenen-VerschlussPublication History
                     
                     
                     
                     
Publication Date:
11 April 2011 (online)

Background
Central retinal vein occlusion is frequently associated with cardiovascular risk factors (arterial hypertension, hypercholesterolemia), or local factors such as ocular hypertension. However, in young patients (under 50), haematological and inflammatory factors (e. g. factor V Leiden, mutation of prothrombin, hypercysteinemia) must be further investigated [1] [2].
We report the case of a young patient presenting with a non-ischemic central retinal vein occlusion associated with a G 20210A mutation and discuss the relevance of this result for her relatives.
References
- 1 
            Glueck C J, Wang P, Hutchins R et al. 
            Ocular vascular thrombotic events: central retinal vein and central retinal artery
            occlusions. 
            Clin Appl Thromb Hemost. 
            2008; 
            14 (3) 
            286-294 
            . Epub 2007 Dec 26 
            
            Reference Ris Wihthout Link
- 2 
            Van Cott E M, Laposata M, Harnett M E. 
            Prothrombin gene mutation G 20210A, homocysteine, antiphospholipid antibodies and
            other hypercoagulable states in ocular thrombosis. 
            Blood Coagul Fibrinomysis. 
            2004; 
            15 (5) 
            393-397 
            
            Reference Ris Wihthout Link
- 3 
            De Stefano V, Martinelli I, Mannucci P M et al.. 
            The risk of reccurent venous thromboembolism among heterozygous carriers of G 20210A
            prothrombin gene mutation. 
            British Journal of Heamatology. 
            2001; 
            113 
            630-635 
            
            Reference Ris Wihthout Link
- 4 
            Emmerich J, Rosendaal F R, Cattaneo M et al. 
            Study Group for Pooled-Analysis in Venous Thromboembolism. Combined effect of factor
            V Leiden and prothrombin 20210A on the risk of venous thromboembolism – pooled analysis
            of 8 case-control studies including 2310 cases and 3204 controls. 
            Thromb Haemost. 
            2001; 
            86 (3) 
            809-816 
            
            Reference Ris Wihthout Link
- 5 
            Isobel D, Walker M, Greaves F E et al. 
            Guidelines Investigation and Management of Heritable Thrombophilia. 
            British Journal of Haematology. 
            2001; 
            114 
            512-528 
            
            Reference Ris Wihthout Link
- 6 
            Zotz R B, Gerhardt A, Scharf R E. 
            Inherited thrombophilia and gestational venous thromboembolism. 
            Best Pract Res Clin Haematol. 
            2003; 
            16 (2) 
            243-259 
            
            Reference Ris Wihthout Link
- 7 
            Baglin T, Gray E, Greaves M et al. 
            Clinical guidelines for testing for heritable thrombophilia. 
            British Journal of Haematology. 
            2001; 
            149 
            209-220 
            
            Reference Ris Wihthout Link
- 8 
            Yau W Y, Lee P, Wong T Y et al. 
            Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. 
            Internal Medicine Journal. 
            2008; 
            38 
            904-910 
            
            Reference Ris Wihthout Link
PD Dr. Thomas J. Wolfensberger
         Jules Gonin Eye Hospital (Chairman: Professor Zografos Leonidas)
         
         Avenue de France, 15
         
         1004 Lausanne
         
         Switzerland
         
         Phone:  ++ 41/21/6 26 83 07
         
         Fax:  ++ 41/21/6 26 88 88
         
         Email: thomas.wolfensberger@fa2.ch
         
         
 
     
      
    